Literature DB >> 33280520

Interleukin-8 Promotes Epithelial-to-Mesenchymal Transition via Downregulation of Mir-200 Family in Breast Cancer Cells.

Jin Zhang1, Nan Shao1, Xiaoyu Yang2, Chuanbo Xie3, Yawei Shi1, Ying Lin1.   

Abstract

The microRNA-200 (miR-200) family has been reported to be vital for the inhibition of epithelial-to-mesenchymal transition (EMT) in tumor cells. The miR-200 family represents a complex multi-factorial regulatory network which has not been well described in breast cancer. This study aimed to clarify the underlying regulatory association between IL-8 and miR-200 family in the process of EMT in breast cancer cell. In estrogen-receptor (ER) positive breast cancer cell line MCF-7, IL-8 overexpression cells were performed by lentivirus transfection as endogenous regulation with additional exogenous IL-8 stimulation. Transient overexpressions of miR-200 family were performed after endogenous or exogenous IL-8 overexpression in MCF-7 cells. IL-8 knockdown cells were constructed via siRNA and shRNA transfection in triple negative breast cancer cell line MDA-MB-231. N-cadherin, vimentin and ZEB2 were down-regulated and E-cadherin was up-regulated in IL-8 knockdown group compared with control group. On the other hand, N-cadherin, vimentin and ZEB2 were up-regulated and E-cadherin was down-regulated in IL-8 overexpression group compared with control group. This indicated IL-8 promotes EMT in breast cancer cells. Transwell assay showed that IL-8 increased the migration and invasiveness of tumor cells. Furthermore, we performed transient overexpression of miR-200 family after endogenous or exogenous IL-8 overexpression in MCF-7 cells, which showed that the miR-200 family could inhibit EMT induced by IL-8. IL-8 promoted EMT via downregulation of miR-200 family expression in breast cancer cells and increases tumor cell migration and invasion.

Entities:  

Keywords:  Breast cancer; Epithelial-to-mesenchymal transition; Interleukin-8; Invasion; Migration; miR-200

Year:  2020        PMID: 33280520     DOI: 10.1177/1533033820979672

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  2 in total

Review 1.  Cytokines and microRNAs in SARS-CoV-2: What do we know?

Authors:  Fahimeh Zamani Rarani; Bahman Rashidi; Mohammad Hassan Jafari Najaf Abadi; Michael R Hamblin; Seyed Mohammad Reza Hashemian; Hamed Mirzaei
Journal:  Mol Ther Nucleic Acids       Date:  2022-06-25       Impact factor: 10.183

2.  The association of immunosurveillance and distant metastases in colorectal cancer.

Authors:  Sven Jacob; Vindi Jurinovic; Christopher Lampert; Elise Pretzsch; Jörg Kumbrink; Jens Neumann; Ren Haoyu; Bernhard W Renz; Thomas Kirchner; Markus O Guba; Jens Werner; Martin K Angele; Florian Bösch
Journal:  J Cancer Res Clin Oncol       Date:  2021-09-02       Impact factor: 4.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.